Trademark Snap Shot ITU Unit Action (Table presents the data on ITU Unit Action) |
|||
OVERVIEW |
|||
SERIAL NUMBER | 88233662 | FILING DATE | 12/18/2018 |
REG NUMBER | 0000000 | REG DATE | N/A |
REGISTER | PRINCIPAL | MARK TYPE | SERVICE MARK |
INTL REG # | N/A | INTL REG DATE | N/A |
TM ATTORNEY | JACKSON, WILLIAM D |
L.O. ASSIGNED | 117 |
PUB INFORMATION |
|||
RUN DATE | 08/13/2020 | ||
PUB DATE | 05/28/2019 | ||
STATUS | 748-STATEMENT OF USE - TO EXAMINER | ||
STATUS DATE | 08/12/2020 | ||
LITERAL MARK ELEMENT | KEYSTONE | ||
DATE ABANDONED | N/A | DATE CANCELLED | N/A |
SECTION 2F | NO | SECTION 2F IN PART | NO |
SECTION 8 | NO | SECTION 8 IN PART | NO |
SECTION 15 | NO | REPUB 12C | N/A |
RENEWAL FILED | NO | RENEWAL DATE | N/A |
DATE AMEND REG | N/A |
FILING BASIS |
|||||
FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
44D | NO | 44D | NO | 44D | NO |
44E | NO | 44E | NO | 44E | NO |
66A | NO | 66A | NO | ||
NO BASIS | NO | NO BASIS | NO |
MARK DATA |
|
STANDARD CHARACTER MARK | YES |
LITERAL MARK ELEMENT | KEYSTONE |
MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
PARTY TYPE | 20-OWNER AT PUBLICATION |
NAME | Paratek Pharmaceuticals, Inc. |
ADDRESS | 75 Park Plaza Boston, MA 02116 |
ENTITY | 03-CORPORATION |
CITIZENSHIP | Delaware |
GOODS AND SERVICES |
|
INTERNATIONAL CLASS | 042 |
DESCRIPTION TEXT | Providing an interactive web site featuring technology that enables users to access, track, monitor, and generate reports relating to antibiotics and bacterial susceptibility and resistance patterns; providing an internet-based database of cumulative medical and scientific research data on bacterial susceptibility surveillance to monitor changes in resistance patterns and provide doctors and the healthcare community information on the activity of an antibacterial drug to an organism over time |
INTERNATIONAL CLASS | 044 |
DESCRIPTION TEXT | Medical information services, namely, reporting of drug-resistance patterns over time; providing an internet-based database of cumulative data on bacterial susceptibility surveillance to monitor changes in resistance patterns and provide doctors and the healthcare community information on the activity of an antibacterial drug to an organism over time for medical treatment purposes |
GOODS AND SERVICES CLASSIFICATION |
|||||||
INTERNATIONAL CLASS | 042 | FIRST USE DATE | 04/30/2019 | FIRST USE IN COMMERCE DATE | 04/30/2019 | CLASS STATUS | 6-ACTIVE |
INTERNATIONAL CLASS | 044 | FIRST USE DATE | 04/30/2019 | FIRST USE IN COMMERCE DATE | 04/30/2019 | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
CHANGE IN REGISTRATION | NO |
PROSECUTION HISTORY |
||||
DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
08/13/2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 028 |
08/12/2020 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | 027 |
07/23/2020 | IUAF | S | USE AMENDMENT FILED | 026 |
08/12/2020 | EX2G | S | EXTENSION 2 GRANTED | 025 |
07/15/2020 | EXT2 | S | EXTENSION 2 FILED | 024 |
08/12/2020 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | 023 |
07/23/2020 | EEXT | I | TEAS EXTENSION RECEIVED | 022 |
07/15/2020 | EISU | I | TEAS STATEMENT OF USE RECEIVED | 021 |
01/21/2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 020 |
01/17/2020 | EX1G | S | EXTENSION 1 GRANTED | 019 |
01/17/2020 | EXT1 | S | EXTENSION 1 FILED | 018 |
01/17/2020 | EEXT | I | TEAS EXTENSION RECEIVED | 017 |
07/23/2019 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 016 |
05/28/2019 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 015 |
05/28/2019 | PUBO | A | PUBLISHED FOR OPPOSITION | 014 |
05/08/2019 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 013 |
04/19/2019 | ALIE | A | ASSIGNED TO LIE | 012 |
04/01/2019 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 011 |
04/01/2019 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | 010 |
04/01/2019 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 009 |
04/01/2019 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | 008 |
04/01/2019 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | 007 |
03/22/2019 | GPRN | O | NOTIFICATION OF PRIORITY ACTION E-MAILED | 006 |
03/22/2019 | GPRA | F | PRIORITY ACTION E-MAILED | 005 |
03/22/2019 | CPRA | R | PRIORITY ACTION WRITTEN | 004 |
03/14/2019 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
01/10/2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
12/21/2018 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
ATTORNEY | Keith Toms, Esq. |
CORRESPONDENCE ADDRESS | Keith Toms, Esq. MCCARTER & ENGLISH, LLP 265 FRANKLIN STREET BOSTON, MA 02110 |
DOMESTIC REPRESENTATIVE | NONE |
PRIOR OWNER INFORMATION |
|
PARTY TYPE | 10-ORIGINAL APPLICANT |
NAME | Paratek Pharmaceuticals, Inc. |
ADDRESS | 75 Park Plaza Boston, MA 02116 |
ENTITY | 03-CORPORATION |
CITIZENSHIP | Delaware |